8月15日,本土GLP-1药企银诺医药-B(02591.HK)正式在港股敲钟,发行价为18.68港元/股。上市首日,银诺医药开盘涨超280%,盘中最高攀至74.00港元/股,最终报收57.25港元/股,涨206.48%,总市值逾260亿港元。银诺医药成立于2014年,是一家致力于为代谢性疾病患者提供创新的,可及且可负担的高质量药品的生物制药公司,其目前拥有包括多项针对糖尿病、肥胖,非酒精性脂肪...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.